| Dr Donald Charles Falgoust, MD | |
|
1980 Tybee Lane, Lake Charles, LA 70605-2400 | |
| (337) 479-0963 | |
| (337) 477-1912 |
| Full Name | Dr Donald Charles Falgoust |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 31 Years |
| Location | 1980 Tybee Lane, Lake Charles, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538168323 | NPI | - | NPPES |
| 1695807 | Medicaid | LA | |
| 5CT98 | Other | LA | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD12137R (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Falgoust Eye Medical And Surgical | 9739197880 | 2 |
News Archive
Post-menopausal women whose doctors prescribe hormone replacement therapy for severe hot flashes and other menopause symptoms may want to consider taking low doses of Food and Drug Administration-approved bioidentical forms of estrogen or getting their hormones via a transdermal patch.
Through x-ray crystallography and kinase-inhibitor specificity profiling, University of California San Diego School of Medicine researchers, in collaboration with researchers at Peking University and Zhejiang University, reveal that curcumin, a natural occurring chemical compound found in the spice turmeric, binds to the kinase enzyme dual-specificity tyrosine-regulated kinase 2 at the atomic level.
Boston Scientific Corporation today welcomed one-year data from the SPIRIT IV clinical trial comparing the XIENCE V((R)) (PROMUS((R))) Everolimus-Eluting Coronary Stent System to the TAXUS((R)) Express2(TM) Paclitaxel-Eluting Coronary Stent System. The results support the benefits of paclitaxel-eluting stents in diabetic patients. The trial enrolled 3,690 patients, including 1,140 diabetics, the largest diabetic subset ever studied in a drug-eluting stent clinical trial.
A federal judge in Arizona has issued an injunction barring Arizona from enforcing a law that halts state money from flowing to Planned Parenthood, saying the women's health provider's challenge will likely succeed on a "freedom-of-choice" provision in Medicaid.
A recent article, published in the journal Nature Human Behaviour, analyses quantitatively the NPIs implemented in different geographies and their impact on the effective reproduction number, Rt, of COVID-19.
› Verified 6 days ago
| Entity Name | Falgoust Eye Medical And Surgical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649285040 PECOS PAC ID: 9739197880 Enrollment ID: O20060330000537 |
News Archive
Post-menopausal women whose doctors prescribe hormone replacement therapy for severe hot flashes and other menopause symptoms may want to consider taking low doses of Food and Drug Administration-approved bioidentical forms of estrogen or getting their hormones via a transdermal patch.
Through x-ray crystallography and kinase-inhibitor specificity profiling, University of California San Diego School of Medicine researchers, in collaboration with researchers at Peking University and Zhejiang University, reveal that curcumin, a natural occurring chemical compound found in the spice turmeric, binds to the kinase enzyme dual-specificity tyrosine-regulated kinase 2 at the atomic level.
Boston Scientific Corporation today welcomed one-year data from the SPIRIT IV clinical trial comparing the XIENCE V((R)) (PROMUS((R))) Everolimus-Eluting Coronary Stent System to the TAXUS((R)) Express2(TM) Paclitaxel-Eluting Coronary Stent System. The results support the benefits of paclitaxel-eluting stents in diabetic patients. The trial enrolled 3,690 patients, including 1,140 diabetics, the largest diabetic subset ever studied in a drug-eluting stent clinical trial.
A federal judge in Arizona has issued an injunction barring Arizona from enforcing a law that halts state money from flowing to Planned Parenthood, saying the women's health provider's challenge will likely succeed on a "freedom-of-choice" provision in Medicaid.
A recent article, published in the journal Nature Human Behaviour, analyses quantitatively the NPIs implemented in different geographies and their impact on the effective reproduction number, Rt, of COVID-19.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald Charles Falgoust, MD Po Box 4765, Lake Charles, LA 70606-4765 Ph: (337) 477-0963 | Dr Donald Charles Falgoust, MD 1980 Tybee Lane, Lake Charles, LA 70605-2400 Ph: (337) 479-0963 |
News Archive
Post-menopausal women whose doctors prescribe hormone replacement therapy for severe hot flashes and other menopause symptoms may want to consider taking low doses of Food and Drug Administration-approved bioidentical forms of estrogen or getting their hormones via a transdermal patch.
Through x-ray crystallography and kinase-inhibitor specificity profiling, University of California San Diego School of Medicine researchers, in collaboration with researchers at Peking University and Zhejiang University, reveal that curcumin, a natural occurring chemical compound found in the spice turmeric, binds to the kinase enzyme dual-specificity tyrosine-regulated kinase 2 at the atomic level.
Boston Scientific Corporation today welcomed one-year data from the SPIRIT IV clinical trial comparing the XIENCE V((R)) (PROMUS((R))) Everolimus-Eluting Coronary Stent System to the TAXUS((R)) Express2(TM) Paclitaxel-Eluting Coronary Stent System. The results support the benefits of paclitaxel-eluting stents in diabetic patients. The trial enrolled 3,690 patients, including 1,140 diabetics, the largest diabetic subset ever studied in a drug-eluting stent clinical trial.
A federal judge in Arizona has issued an injunction barring Arizona from enforcing a law that halts state money from flowing to Planned Parenthood, saying the women's health provider's challenge will likely succeed on a "freedom-of-choice" provision in Medicaid.
A recent article, published in the journal Nature Human Behaviour, analyses quantitatively the NPIs implemented in different geographies and their impact on the effective reproduction number, Rt, of COVID-19.
› Verified 6 days ago
Margaret Young Carter, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1717 Oak Park Blvd, #1, Lake Charles, LA 70601 Phone: 337-478-3810 | |
Dr. Don Alan Bravin, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1767 Imperial Blvd, Lake Charles, LA 70605 Phone: 337-478-3810 Fax: 337-478-6360 | |
Brian Mikulla, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1980 Tybee St, Lake Charles, LA 70605 Phone: 337-477-0963 Fax: 337-477-1912 | |
Gerard Guidry, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Walters St, Lake Charles, LA 70607 Phone: 337-480-8066 Fax: 337-480-8061 | |
Alan Daniel Lacoste, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1767 Imperial Blvd, Lake Charles, LA 70605 Phone: 337-478-3810 Fax: 337-478-6360 | |
Dr. Larry Don Stewart, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1767 Imperial Blvd, Lake Charles, LA 70605 Phone: 337-478-3810 Fax: 337-478-6360 | |
Marcy L. Hanudel, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1767 Imperial Blvd, Lake Charles, LA 70605 Phone: 337-478-3810 |